Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors, activators |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H26BN3O9 |
InChIKeySVWHNLVZPGXBNS-MHDNXTQBSA-N |
CAS Registry890402-81-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | Mexico | 01 Apr 2007 | |
Diabetes Mellitus, Type 2 | Phase 2 | India | 01 Apr 2007 | |
Diabetes Mellitus, Type 2 | Phase 2 | United States | 01 Apr 2007 | |
Diabetes Mellitus, Type 2 | Phase 2 | Argentina | 01 Apr 2007 | |
Diabetes Mellitus, Type 2 | Phase 2 | Canada | 01 Apr 2007 |